Sustained Post-Pandemic Demand: Post-COVID-19, global demand for disposable medical protective gowns (especially surgical gowns) remains high, driving growth in the nonwovens market. The market is expected to expand at a 6.2% compound annual growth rate (CAGR) by 2030.

Upgraded Infection Control Standards: Hospitals and healthcare facilities are increasing their demand for surgical gowns with higher levels of protection (e.g., AAMI Levels 3-4), driving the adoption of high-performance nonwovens (e.g., SMS structures). - Emerging Market Medical Infrastructure: The expansion of medical facilities in the Asia-Pacific, Middle East, and Africa regions is driving demand for surgical gowns, particularly in India and China (which account for over 40% of the Asia-Pacific market growth).

Combining Lightweight with High Protection: Companies are developing lighter, more breathable nonwoven fabrics (such as microfiber spunbond) that meet ASTM F1671 (blood penetration resistance) and ASTM F1670 (antiviral) standards.

The Rise of Sustainable Materials: The proportion of bio-based nonwovens (such as PLA) and recyclable materials is increasing, and EU regulations (such as the SUP Directive) are driving environmental transformation.

Antibacterial Coating Technology: Nonwoven fabrics infused with silver ions or copper-based antimicrobial agents are becoming a high-end product trend, reducing the risk of postoperative infection.

North America Dominates the Market (35% in 2025): Strict US FDA regulations and hospital procurement standards drive demand for high-quality nonwovens, giving companies like 3M and DuPont a technological advantage.

Europe Accelerates Green Transformation: Germany and France promote biodegradable surgical gowns, and the penetration rate of bio-based nonwovens in the EU is expected to reach 18% in 2025.

Intense Price Competition in Asia Pacific: Chinese manufacturers (such as the Berry Global joint venture) are gaining market share with low-cost SMS nonwovens, but the high-end market remains reliant on imports.

Consolidation of Leading Companies: The top five companies (Berry Global, Ahlstrom, Kimberly-Clark, etc.) control over 60% of the global market share and are expanding production capacity through mergers and acquisitions (such as Berry's acquisition of Freudenberg's medical division in 2024).

Localized Production Trend: To reduce transportation costs, multinational companies are setting up factories in India and Vietnam, shortening delivery times to regional hospitals.

Raw Material Price Fluctuations: PP (polypropylene) price fluctuations will impact profit margins in 2024, prompting companies to turn to recycled polypropylene to reduce costs.

It seems that there is no text provided for translation. Please provide the text you would like me to translate.

5. Sustainability and Regulatory Challenges

Waste Management Pressure: Concerns about the medical waste generated by disposable surgical gowns are driving the development of reusable nonwovens (those sterilized 5-10 times).

Carbon Footprint Regulation: The EU Carbon Border Tax (CBAM) is forcing companies to adopt low-carbon production processes, such as energy-saving technologies in meltblown nonwoven production.

It seems that there is no text provided for translation. Please provide the text you would like me to translate.

Future Outlook (2025-2030)

Smart Nonwovens: Technology that integrates sensors to monitor surgical gown damage or contamination is entering the pilot phase.

Customized Demand: Reinforced nonwoven products for obese patients or specialized surgeries (such as radiation protection) are experiencing significant growth.

Divergence in Price-Sensitive Markets: Emerging markets continue to focus on low-cost SMS, while high-end markets in Europe and the United States are focusing on composite film nonwovens (such as PE/PET multilayer structures).

Recommended: Companies need to balance protection performance with sustainability, monitor FDA/EU MDR regulatory updates, and establish localized supply chains in Asia Pacific to reduce costs.